From: A novel model for predicting immunotherapy response and prognosis in NSCLC patients
Survival prediction | C-index | 95 CI% | p |
---|---|---|---|
Training cohort | |||
  OS | |||
    RF model | 0.803 | 0.763–0.843 |  |
    Nomogram model | 0.507 | 0.448–0.566 |  |
    SIS | 0.541 | 0.488–0.593 |  |
    LIPI | 0.534 | 0.488–0.580 |  |
    RF model vs Nomogram model |  |  | <0.001 |
    RF model vs SIS |  |  | <0.001 |
    RF model vs LIPI |  |  | <0.001 |
  PFS | |||
    RF model | 0.663 | 0.617–0.710 |  |
    Nomogram model | 0.502 | 0.455–0.549 |  |
    SIS | 0.508 | 0.461–0.555 |  |
    LIPI | 0.528 | 0.492–0.565 |  |
    RF model vs Nomogram model |  |  | <0.001 |
    RF model vs SIS |  |  | <0.001 |
    RF model vs LIPI |  |  | <0.001 |
Validation cohort | |||
  OS | |||
    RF model | 0.712 | 0.652–0.772 |  |
    Nomogram model | 0.501 | 0.415–0.586 |  |
    SIS | 0.557 | 0.497–0.618 |  |
    LIPI | 0.501 | 0.442–0.560 |  |
    RF model vs Nomogram model |  |  | <0.001 |
    RF model vs SIS |  |  | <0.001 |
    RF model vs LIPI |  |  | <0.001 |
  PFS | |||
    RF model | 0.711 | 0.658–0.765 |  |
    Nomogram model | 0.511 | 0.443–0.580 |  |
    SIS | 0.515 | 0.453–0.577 |  |
    LIPI | 0.512 | 0.462–0.562 |  |
    RF model vs Nomogram model |  |  | <0.001 |
    RF model vs SIS |  |  | <0.001 |
    RF model vs LIPI |  |  | <0.001 |